These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11132897

  • 1. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits.
    Burgalassi S, Chetoni P, Panichi L, Boldrini E, Saettone MF.
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):497-509. PubMed ID: 11132897
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits.
    Acheampong AA, Breau A, Shackleton M, Luo W, Lam S, Tang-Liu DD.
    J Ocul Pharmacol Ther; 1995 Dec; 11(4):489-502. PubMed ID: 8574812
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.
    Lee VH, Luo AM, Li SY, Podder SK, Chang JS, Ohdo S, Grass GM.
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2948-57. PubMed ID: 1917398
    [Abstract] [Full Text] [Related]

  • 6. Ocular mini-tablets for controlled release of timolol: evaluation in rabbits.
    Chetoni P, Mariotti Bianchi L, Giannaccini B, Saettone MF, Conte U, Sangalli ME.
    J Ocul Pharmacol Ther; 1996 Oct; 12(3):245-52. PubMed ID: 8875330
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological evaluation of a new timolol/pilocarpine formulation.
    Bucolo C, Spadaro A, Mangiafico S.
    Ophthalmic Res; 1998 Oct; 30(2):101-6. PubMed ID: 9523288
    [Abstract] [Full Text] [Related]

  • 8. Ocular pharmacokinetic/pharmacodynamic modeling for timolol in rabbits using a telemetry system.
    Sakanaka K, Kawazu K, Tomonari M, Kitahara T, Nakashima M, Nishida K, Nakamura J, Sasaki H, Higuchi S.
    Biol Pharm Bull; 2008 May; 31(5):970-5. PubMed ID: 18451528
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improvement of the ocular bioavailability of timolol by sorbic acid.
    Higashiyama M, Inada K, Ohtori A, Tojo K.
    Int J Pharm; 2004 Mar 19; 272(1-2):91-8. PubMed ID: 15019072
    [Abstract] [Full Text] [Related]

  • 11. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects.
    Huang SF, Chen JL, Yeh MK, Chiang CH.
    J Ocul Pharmacol Ther; 2005 Dec 19; 21(6):445-53. PubMed ID: 16386086
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
    Battistini FD, Tártara LI, Boiero C, Guzmán ML, Luciani-Giaccobbe LC, Palma SD, Allemandi DA, Manzo RH, Olivera ME.
    Eur J Pharm Sci; 2017 Jul 15; 105():188-194. PubMed ID: 28506871
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate.
    Arnold JJ, Hansen MS, Gorman GS, Inoue T, Rao V, Spellen S, Hunsinger RN, Chapleau CA, Pozzo-Miller L, Stamer WD, Challa P.
    Invest Ophthalmol Vis Sci; 2013 Feb 07; 54(2):1118-26. PubMed ID: 23307957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.